Related Experiment Video
Updated: May 31, 2026
06:15
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
[Aspergillus tracheobronchitis in a lung transplant recipient]
Cristina López García-Gallo1, Christian García-Fadul, Rosalía Laporta-Hernández
1Servicio de Neumología, Hospital Puerta de Hierro, Majadahonda, Madrid, España. crisneumo@hotmail.com
Revista Iberoamericana De Micologia
|June 25, 2011
Summary
Aspergillus tracheobronchitis, a rare complication in lung transplant recipients, requires early diagnosis and prompt antifungal treatment. This case highlights successful management through voriconazole, debridement, and continued prophylaxis, improving patient outcomes.
Area of Science:
- Pulmonology
- Transplant Surgery
- Infectious Diseases
Background:
- Aspergillus tracheobronchitis is an uncommon pulmonary aspergillosis complication, primarily affecting lung transplant recipients.
- It involves only the tracheobronchial tree without lung parenchyma invasion.
- Early diagnosis is crucial to prevent infection progression and airway complications.
Observation:
- A 56-year-old bilateral lung transplant recipient for COPD developed Aspergillus tracheobronchitis.
- Bronchoscopy revealed pseudomembranes causing 50% stenosis of the right bronchial anastomosis.
- Aspergillus fumigatus was identified via biopsy and bronchial aspirate.
Findings:
- Treatment included voriconazole, bronchial debridement, and continued nebulized liposomal amphotericin B prophylaxis.
- The patient achieved resolution of endobronchial lesions and negative cultures within ten weeks.
- This demonstrates the efficacy of a multi-modal treatment approach.
Implications:
- Aspergillus tracheobronchitis is a significant complication in lung transplant recipients.
- Prompt diagnosis and aggressive antifungal therapy, including local debridement, are vital for favorable outcomes.
- New antifungal agents and treatment strategies can improve prognosis in these patients.
Related Concept Videos
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...